Addition of danicopan to ravulizumab or eculizumab in patients with paroxysmal nocturnal haemoglobinuria and clinically significant extravascular haemolysis (ALPHA): a double-blind, randomised, phase 3 trial

Jong Wook Lee, Yasuo Mori, Jun‐ichi Nishimura et al.|The Lancet Haematology|2023

Cited by 88